Effect of drug therapy on net cholesterol efflux capacity of HDL-enriched serum in rheumatoid arthritis

BACKGROUND: Patients with rheumatoid arthritis (RA) have increased coronary heart disease (CHD) risk. Some RA therapies may modify this risk, but underlying mechanisms are unclear. HDL’s cholesterol efflux capacity is associated with reduced CHD risk in non-RA populations; however, inflammation may...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Arthritis Rheumatol
Egile Nagusiak: Ormseth, Michelle J., Yancey, Patricia G., Solus, Joseph F., Bridges, S. Louis, Curtis, Jeffrey R., Linton, MacRae F., Fazio, Sergio, Davies, Sean S., Roberts, L. Jackson, Vickers, Kasey C., Kon, Valentina, Stein, C. Michael
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: 2016
Gaiak:
Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC5001900/
https://ncbi.nlm.nih.gov/pubmed/26991245
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/art.39675
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak